51 employees
At GTx, They focus on the development of small molecules that selectively modulate the effects of certain hormones produced by the body.
1997
$49M
from 3 investors over 3 rounds
GTx, Inc. raised $49M on September 26, 2017
Investors: Aisling Capital and Abingworth
GTx, Inc. raised $20M on August 20, 2003
Investors: MB Venture Partners, LLC